Quickmed Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 6.20%
- Profit Growth 186.79%
- Ebitda 193.51%
- Net Worth 42.45%
- Total Assets 33.70%
About Quickmed Healthcare
Quickmed Healthcare Private Limited (QHPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 June 2012 and has a history of 12 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Jain and Ish Chadha serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110DL2012PTC237153
-
Company No.
237153
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jun 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Quickmed Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Jain
|
Director | 27-Mar-2013 | Current |
|
Ish Chadha
|
Director | 17-Sep-2015 | Current |
Financial Performance of Quickmed Healthcare.
Quickmed Healthcare Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.2% increase. The company also saw a substantial improvement in profitability, with a 186.79% increase in profit. The company's net worth Soared by an impressive increase of 42.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quickmed Healthcare?
In 2020, Quickmed Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sakshi Poly Tubes Private LimitedRakesh Jain is a mutual person
-
Scope Products Private Limited.
Rakesh Jain is a mutual person
-
Sapshi Electronics Private Limited
Rakesh Jain is a mutual person
-
Tanya Finvest Private Limited
Rakesh Jain is a mutual person
-
Jenson Finvest Private Limited
Rakesh Jain is a mutual person
-
Sakshi Capital Private Limited
Rakesh Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Quickmed Healthcare?
Unlock and access historical data on people associated with Quickmed Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quickmed Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quickmed Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
